336 related articles for article (PubMed ID: 17291938)
21. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P
Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
[TBL] [Abstract][Full Text] [Related]
22. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
Arora S; Clarke K; Srinivasan V; Gradman A
QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392
[TBL] [Abstract][Full Text] [Related]
23. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
24. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
[TBL] [Abstract][Full Text] [Related]
26. Milrinone increases flow in coronary artery bypass grafts after cardiopulmonary bypass: a prospective, randomized, double-blind, placebo-controlled study.
Arbeus M; Axelsson B; Friberg O; Magnuson A; Bodin L; Hultman J
J Cardiothorac Vasc Anesth; 2009 Feb; 23(1):48-53. PubMed ID: 18834820
[TBL] [Abstract][Full Text] [Related]
27. Effect of nesiritide in patients with acute decompensated heart failure.
O'Connor CM; Starling RC; Hernandez AF; Armstrong PW; Dickstein K; Hasselblad V; Heizer GM; Komajda M; Massie BM; McMurray JJ; Nieminen MS; Reist CJ; Rouleau JL; Swedberg K; Adams KF; Anker SD; Atar D; Battler A; Botero R; Bohidar NR; Butler J; Clausell N; Corbalán R; Costanzo MR; Dahlstrom U; Deckelbaum LI; Diaz R; Dunlap ME; Ezekowitz JA; Feldman D; Felker GM; Fonarow GC; Gennevois D; Gottlieb SS; Hill JA; Hollander JE; Howlett JG; Hudson MP; Kociol RD; Krum H; Laucevicius A; Levy WC; Méndez GF; Metra M; Mittal S; Oh BH; Pereira NL; Ponikowski P; Tang WH; Tanomsup S; Teerlink JR; Triposkiadis F; Troughton RW; Voors AA; Whellan DJ; Zannad F; Califf RM
N Engl J Med; 2011 Jul; 365(1):32-43. PubMed ID: 21732835
[TBL] [Abstract][Full Text] [Related]
28. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
Tardif JC; Carrier M; Kandzari DE; Emery R; Cote R; Heinonen T; Zettler M; Hasselblad V; Guertin MC; Harrington RA;
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1604-11. PubMed ID: 17532963
[TBL] [Abstract][Full Text] [Related]
29. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
[TBL] [Abstract][Full Text] [Related]
30. Investigation and analysis of incidence of awareness in patients undergoing cardiac surgery in Beijing, China.
Wang Y; Yue Y; Sun YH; Wu AS; Wu QW; Zhang YQ; Feng CS
Chin Med J (Engl); 2005 Jul; 118(14):1190-4. PubMed ID: 16117864
[TBL] [Abstract][Full Text] [Related]
31. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL
J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
[TBL] [Abstract][Full Text] [Related]
32. Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting.
Sokos GG; Bolukoglu H; German J; Hentosz T; Magovern GJ; Maher TD; Dean DA; Bailey SH; Marrone G; Benckart DH; Elahi D; Shannon RP
Am J Cardiol; 2007 Sep; 100(5):824-9. PubMed ID: 17719327
[TBL] [Abstract][Full Text] [Related]
33. Is the use of cardiopulmonary bypass for isolated coronary artery bypass an independent predictor of mortality and morbidity in patients with severe left ventricular dysfunction?
Qiu ZB; Chen X; Xu M; Shi KH; Jiang YS; Xiao LQ
Chin Med J (Engl); 2008 Dec; 121(23):2397-402. PubMed ID: 19102956
[TBL] [Abstract][Full Text] [Related]
34. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
Michaels AD; Chatterjee K; De Marco T
J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633
[TBL] [Abstract][Full Text] [Related]
35. Imaging and diagnostic testing: diastolic dysfunction after coronary artery bypass grafting: a frequent finding of clinical significance not influenced by intravenous calcium.
Ekery DL; Davidoff R; Orlandi QG; Apstein CS; Hesselvik JF; Shemin RJ; Shapira OM
Am Heart J; 2003 May; 145(5):896-902. PubMed ID: 12766750
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of nesiritide in pediatric heart failure.
Jefferies JL; Price JF; Denfield SW; Chang AC; Dreyer WJ; McMahon CJ; Grenier MA; Clunie SK; Thomas A; Moffett BS; Wann TS; Smith EO; Towbin JA
J Card Fail; 2007 Sep; 13(7):541-8. PubMed ID: 17826644
[TBL] [Abstract][Full Text] [Related]
37. Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study.
Meco M; Cirri S; Gallazzi C; Magnani G; Cosseta D
Eur J Cardiothorac Surg; 2007 Aug; 32(2):319-25. PubMed ID: 17574858
[TBL] [Abstract][Full Text] [Related]
38. Natriuretic peptides in the perioperative management of cardiac surgery patients.
Moazami N; Oz MC
Heart Surg Forum; 2005; 8(3):E151-7. PubMed ID: 16183564
[TBL] [Abstract][Full Text] [Related]
39. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
[TBL] [Abstract][Full Text] [Related]
40. Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose HANP Infusion Therapy during cardiac surgery) trial for CKD.
Sezai A; Hata M; Niino T; Yoshitake I; Unosawa S; Wakui S; Kimura H; Shiono M; Takayama T; Hirayama A
J Am Coll Cardiol; 2011 Aug; 58(9):897-903. PubMed ID: 21851876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]